Phase I clinical and pharmacologic study of docetaxel and gemcitabine in patients with advanced solid tumors; a novel two week schedule

被引：0
|
作者：
Obrocea, M
Davis, TH
Lewis, LD
Maurer, LH
Pipas, JM
Smith, EL
Meyer, LP
Hammond, S
Rigas, JR
机构：
[1] Dartmouth Coll, Hitchcock Med Ctr, Lebanon, NH 03756 USA
[2] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
363
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [31] Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors
    Tsao, AS
    Shin, DM
    Palmer, JL
    Lee, JS
    Glisson, BS
    CANCER, 2004, 100 (10) : 2240 - 2245
  • [32] Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: Preliminary evidence of clinical activity
    Adjei, AA
    Klein, CE
    Kastrissios, H
    Goldberg, RM
    Alberts, SR
    Pitot, HC
    Sloan, JA
    Reid, JM
    Hanson, LJ
    Atherton, P
    Rubin, J
    Erlichman, C
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) : 1116 - 1123
  • [33] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Brell, Joanna M.
    Krishnamurthi, Smitha S.
    Rath, Linda
    Bokar, Joseph A.
    Savvides, Panayiotis
    Gibbons, Joseph
    Cooney, Matthew M.
    Meropol, Neal J.
    Ivy, Percy
    Dowlati, Afshin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 547 - 553
  • [34] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Joanna M. Brell
    Smitha S. Krishnamurthi
    Linda Rath
    Joseph A. Bokar
    Panayiotis Savvides
    Joseph Gibbons
    Matthew M. Cooney
    Neal J. Meropol
    Percy Ivy
    Afshin Dowlati
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 547 - 553
  • [35] A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors
    Fury, MG
    Krug, LM
    Azzoli, CG
    Sharma, S
    Kemeny, N
    Wu, N
    Kris, MG
    Rizvi, NA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (05) : 671 - 677
  • [36] A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors
    Matthew G. Fury
    Lee M. Krug
    Christopher G. Azzoli
    Sunil Sharma
    Nancy Kemeny
    Nian Wu
    Mark G. Kris
    Naiyer A. Rizvi
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 671 - 677
  • [37] Phase I Clinical Trial of Pegylated Liposomal Doxorubicin and Docetaxel in Patients With Advanced Solid Tumors
    Iqbal, Syma
    Tsao-Wei, Denice D.
    Quinn, David I.
    Gitlitz, Barbara J.
    Groshen, Susan
    Aparicio, Ana
    Lenz, Heinz Josef
    El-Khoueiry, Anthony
    Pinski, Jacek
    Garcia, Agustin A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 27 - 31
  • [38] A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors
    Ghalib, Mohammad H.
    Pulla, Mariano Provencio
    Luken, Maria J. De Miguel
    de Juan, Virginia Calvo
    Chaudhary, Imran
    Hammami, M. Bakri
    Vikash, Sindhu
    Maitra, Radhashree
    Martinez, Sara
    Kahatt, Carmen
    Extremera, Sonia
    Fudio, Salvador
    Goel, Sanjay
    INVESTIGATIONAL NEW DRUGS, 2024, : 481 - 491
  • [39] Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumors
    OReilly, S
    Grochow, LB
    Donehower, RC
    Chen, TL
    Bowling, K
    Hartman, NR
    Struck, RF
    Rowinsky, EK
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 1974 - 1984
  • [40] Phase I study of docetaxel and topotecan in patients with solid tumors
    Katherine H. Tkaczuk
    William C. Zamboni
    Nancy S. Tait
    Barry R. Meisenberg
    L. Austin Doyle
    Martin J. Edelman
    Petr F. Hausner
    Merrill J. Egorin
    David A. Van Echo
    Cancer Chemotherapy and Pharmacology, 2000, 46 : 442 - 448
12345